A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Conditions:   Cardiovascular Diseases;   Type 2 Diabetes Mellitus Interventions:   Drug: Apelin;   Drug: Relaxin;   Drug: Normal saline;   Diagnostic Test: Verapamil;   Diagnostic Test: LN Monomethyl arginine Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge;   AstraZeneca;   MedImmune LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2018 Category: Research Source Type: clinical trials